TargetMol

IR-820

Product Code:
 
TAR-T20870
Product Group:
 
Dyes, Stains, and Probes
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20°C
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T20870-100mg100mg£103.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T20870-500mg500mg£165.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
IR-820 is a near-infrared dye with better stability, good color rendering, and excellent fluorescence penetration. IR-820 is an infrared blood pool contrast agent used to detect and quantify diseased tissue in live animals. IR-820 has maximal Ex and Em of 710 and 820 nm, respectively.
CAS:
172616-80-7
Molecular Weight:
850.48
Purity:
0.98
SMILES:
[Na].O=S(=O)([O-])CCCC[N+]=1C=2C=CC=3C=CC=CC3C2C(C1C=CC4=C(Cl)C(=CC=C5N(C=6C=CC=7C=CC=CC7C6C5(C)C)CCCCS(=O)(=O)O)CCC4)(C)C

References

Prajapati SI, et al. Near-infrared imaging of injured tissue in living subjects using IR-820. Mol Imaging. 2009;8(1):45-54. Fan H, et al. Polydopamine encapsulated new indocyanine green theranostic nanoparticles for enhanced photothermal therapy in cervical cancer HeLa cells. Front Bioeng Biotechnol. 2022;10:984166. Kumar P, et al. IR 820 dye encapsulated in polycaprolactone glycol chitosan: Poloxamer blend nanoparticles for photo immunotherapy for breast cancer. Mater Sci Eng C Mater Biol Appl. 2015;57:321-327. Yan T, et al. PpIX/IR-820 Dual-Modal Therapeutic Agents for Enhanced PDT/PTT Synergistic Therapy in Cervical Cancer. ACS Omega. 2022;7(49):44643-44656. Prajapati SI, et al. Near-infrared imaging of injured tissue in living subjects using IR-820. Mol Imaging. 2009;8(1):45-54.